Reaction
Endocarditis Staphylococcal reporting signals
As of the last recalculation, Endocarditis Staphylococcal appears in 482 FAERS reports alongside 9 co-occurring drug terms. The strongest observed disproportionality signal is RIFAMPICIN (PRR 84.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Rifampicin | 19 | 84.4 | 84.5 |
| Ketoprofen | 13 | 43.9 | 44.0 |
| Cefazolin | 7 | 33.6 | 33.6 |
| Daptomycin | 7 | 33.2 | 33.3 |
| Anti-Thymocyte Globulin (Rabbit) | 6 | 32.5 | 32.5 |
| Brinzolamide | 6 | 30.2 | 30.2 |
| Raltegravir | 11 | 29.4 | 29.4 |
| Baricitinib | 5 | 22.6 | 22.6 |
| Polatuzumab Vedotin | 3 | 13.4 | 13.4 |